AKRO - Cantor starts Akero at buy bullish on upcoming data for NASH drug
2023-09-19 15:40:37 ET
More on Akero Therapeutics
- Seeking Alpha’s Quant Rating on Akero Therapeutics
- Historical earnings data for Akero Therapeutics
- Financial information for Akero Therapeutics
- Akero Therapeutics: An Assessment
- 89bio gains as UBS starts at Buy; cites upcoming data from Akero
For further details see:
Cantor starts Akero at buy, bullish on upcoming data for NASH drug